CA3075474C - Appareil multifonctionnel non invasif de telemesure et systeme en temps reel de surveillance de signaux cliniques et de parametres de sante - Google Patents
Appareil multifonctionnel non invasif de telemesure et systeme en temps reel de surveillance de signaux cliniques et de parametres de sante Download PDFInfo
- Publication number
- CA3075474C CA3075474C CA3075474A CA3075474A CA3075474C CA 3075474 C CA3075474 C CA 3075474C CA 3075474 A CA3075474 A CA 3075474A CA 3075474 A CA3075474 A CA 3075474A CA 3075474 C CA3075474 C CA 3075474C
- Authority
- CA
- Canada
- Prior art keywords
- medical
- monitoring apparatus
- bio
- health monitoring
- signals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036541 health Effects 0.000 title claims abstract description 172
- 238000012544 monitoring process Methods 0.000 title claims abstract description 111
- 230000003287 optical effect Effects 0.000 claims abstract description 105
- 238000000034 method Methods 0.000 claims abstract description 64
- 230000033001 locomotion Effects 0.000 claims abstract description 63
- 230000007958 sleep Effects 0.000 claims abstract description 54
- 239000008280 blood Substances 0.000 claims abstract description 38
- 210000004369 blood Anatomy 0.000 claims abstract description 38
- 230000036387 respiratory rate Effects 0.000 claims abstract description 38
- 230000036772 blood pressure Effects 0.000 claims abstract description 33
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 32
- 239000001301 oxygen Substances 0.000 claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 28
- 230000036760 body temperature Effects 0.000 claims abstract description 27
- 201000002859 sleep apnea Diseases 0.000 claims abstract description 22
- 230000008569 process Effects 0.000 claims abstract description 17
- 208000013016 Hypoglycemia Diseases 0.000 claims abstract description 9
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 9
- 230000002631 hypothermal effect Effects 0.000 claims abstract description 7
- 206010020843 Hyperthermia Diseases 0.000 claims abstract description 6
- 230000036031 hyperthermia Effects 0.000 claims abstract description 6
- 238000005259 measurement Methods 0.000 claims abstract description 6
- 231100000572 poisoning Toxicity 0.000 claims abstract 3
- 230000000607 poisoning effect Effects 0.000 claims abstract 3
- 230000004044 response Effects 0.000 claims description 98
- 238000012549 training Methods 0.000 claims description 42
- 230000001537 neural effect Effects 0.000 claims description 39
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 29
- 101710104624 Proline/betaine transporter Proteins 0.000 claims description 23
- 238000004458 analytical method Methods 0.000 claims description 21
- 230000000747 cardiac effect Effects 0.000 claims description 20
- 239000006260 foam Substances 0.000 claims description 19
- 238000004806 packaging method and process Methods 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 17
- 208000019901 Anxiety disease Diseases 0.000 claims description 15
- 230000036506 anxiety Effects 0.000 claims description 15
- 230000002996 emotional effect Effects 0.000 claims description 15
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 230000035487 diastolic blood pressure Effects 0.000 claims description 10
- 206010021143 Hypoxia Diseases 0.000 claims description 9
- 230000003993 interaction Effects 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 9
- 230000000241 respiratory effect Effects 0.000 claims description 9
- 230000017531 blood circulation Effects 0.000 claims description 8
- 230000008452 non REM sleep Effects 0.000 claims description 8
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 8
- 230000035488 systolic blood pressure Effects 0.000 claims description 8
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 7
- 206010019280 Heart failures Diseases 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 230000004872 arterial blood pressure Effects 0.000 claims description 6
- 230000002060 circadian Effects 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 238000009423 ventilation Methods 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 230000001351 cycling effect Effects 0.000 claims description 5
- 230000007954 hypoxia Effects 0.000 claims description 5
- 230000037323 metabolic rate Effects 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 208000019300 CLIPPERS Diseases 0.000 claims description 4
- 230000003044 adaptive effect Effects 0.000 claims description 4
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- 208000018875 hypoxemia Diseases 0.000 claims description 4
- 238000010295 mobile communication Methods 0.000 claims description 4
- 208000019116 sleep disease Diseases 0.000 claims description 4
- 230000009192 sprinting Effects 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 230000001427 coherent effect Effects 0.000 claims description 3
- 230000017525 heat dissipation Effects 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 208000020685 sleep-wake disease Diseases 0.000 claims description 3
- 230000001360 synchronised effect Effects 0.000 claims description 3
- 230000003442 weekly effect Effects 0.000 claims description 3
- 208000019838 Blood disease Diseases 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 208000014951 hematologic disease Diseases 0.000 claims description 2
- 208000018706 hematopoietic system disease Diseases 0.000 claims description 2
- 238000005204 segregation Methods 0.000 claims 2
- 238000013461 design Methods 0.000 abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 9
- 239000008103 glucose Substances 0.000 abstract description 9
- 206010021113 Hypothermia Diseases 0.000 abstract description 4
- 230000001684 chronic effect Effects 0.000 abstract description 4
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 235000008242 dietary patterns Nutrition 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract description 2
- 238000004611 spectroscopical analysis Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 238000007726 management method Methods 0.000 description 80
- 239000000523 sample Substances 0.000 description 27
- 238000010586 diagram Methods 0.000 description 21
- 208000034965 Nemaline Myopathies Diseases 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 11
- 230000036642 wellbeing Effects 0.000 description 10
- 238000000205 computational method Methods 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 230000003340 mental effect Effects 0.000 description 8
- 230000036544 posture Effects 0.000 description 8
- 230000002596 correlated effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000001061 forehead Anatomy 0.000 description 4
- 238000003672 processing method Methods 0.000 description 4
- 239000010454 slate Substances 0.000 description 4
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000037081 physical activity Effects 0.000 description 3
- 208000020016 psychiatric disease Diseases 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010019345 Heat stroke Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004903 cardiac system Anatomy 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 208000001797 obstructive sleep apnea Diseases 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 240000003492 Neolamarckia cadamba Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 238000012536 packaging technology Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/42—Absorption spectrometry; Double beam spectrometry; Flicker spectrometry; Reflection spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0205—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows
- G01J3/0208—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows using focussing or collimating elements, e.g. lenses or mirrors; performing aberration correction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0286—Constructional arrangements for compensating for fluctuations caused by temperature, humidity or pressure, or using cooling or temperature stabilization of parts of the device; Controlling the atmosphere inside a spectrometer, e.g. vacuum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0291—Housings; Spectrometer accessories; Spatial arrangement of elements, e.g. folded path arrangements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/10—Arrangements of light sources specially adapted for spectrometry or colorimetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/10—Arrangements of light sources specially adapted for spectrometry or colorimetry
- G01J2003/102—Plural sources
- G01J2003/104—Monochromatic plural sources
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N2021/3155—Measuring in two spectral ranges, e.g. UV and visible
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N2021/3181—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using LEDs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/85—Investigating moving fluids or granular solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/062—LED's
- G01N2201/0627—Use of several LED's for spectral resolution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/121—Correction signals
- G01N2201/1211—Correction signals for temperature
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
La présente invention concerne un appareil multifonctionnel sans fil, des instruments de spectrométrie, un système informatique en temps réel et des formes ergonomiques de dispositif pour la surveillance en direct et en télémétrie de paramètres cliniques, de données de santé et d'autres informations médicales vitales. Les paramètres cliniques et les informations médicales comprennent la fréquence du pouls, la fréquence respiratoire, les taux de glycémie en continu, les niveaux de pression artérielle en continu, la variabilité de la fréquence du pouls, le taux de saturation en oxygène, la température corporelle, l'activité bioélectrique, les phases du sommeil, la santé associée au sommeil et d'autres données de signaux biologiques vitaux. L'appareil de télémesure comprend des instruments spectromètres électriques et optiques. Les conceptions des spectromètres et la conception des circuits connexes associés garantissent que le dispositif est sûr biologiquement, léger, à faible consommation d'énergie et portable. La configuration de biocapteur, la conception de matériel complet, le processus informatique et la conception ergonomique permettent la mesure avec une plus grande précision et une plus grande efficacité, même dans des conditions sujettes à des artefacts de mouvement. La conception du système assure également que le processus informatique est réalisé en temps réel, est plus rapide et à faible consommation d'énergie. L'appareil sans fil garde une trace des informations d'utilisateur sur un modèle de régime alimentaire quotidien, une prise de fluide et d'eau, une intensité d'exercice, d'autres données de santé essentielles, et fournit des alertes nécessaires. L'appareil produit des niveaux de stress personnels et aide l'utilisateur à gérer le stress par l'intermédiaire d'exercices pratiques guidés. Le système de gestion de santé fonctionne sur la base des entrées d'utilisateur et des paramètres calculés précédemment. Une fonctionnalité automatisée de maintien des fonctions vitales est intégrée au système, qui peut prévoir des états cliniques chroniques et des risques de santé tels que l'apnée du sommeil, l'hypertension, l'hypoglycémie, l'hyperglycémie, l'hypothermie, l'hyperthermie, l'empoisonnement au CO, les conditions de fatigue et autres.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762557069P | 2017-09-11 | 2017-09-11 | |
| US62/557,069 | 2017-09-11 | ||
| US201862638315P | 2018-03-05 | 2018-03-05 | |
| US62/638,315 | 2018-03-05 | ||
| US201816127228A | 2018-09-11 | 2018-09-11 | |
| US16/127,228 | 2018-09-11 | ||
| PCT/IB2018/058718 WO2019049116A2 (fr) | 2017-09-11 | 2018-11-06 | Appareil multifonctionnel non invasif de télémesure et système en temps réel de surveillance de signaux cliniques et de paramètres de santé |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3075474A1 CA3075474A1 (fr) | 2019-03-14 |
| CA3075474C true CA3075474C (fr) | 2023-12-19 |
Family
ID=65633631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3075474A Active CA3075474C (fr) | 2017-09-11 | 2018-11-06 | Appareil multifonctionnel non invasif de telemesure et systeme en temps reel de surveillance de signaux cliniques et de parametres de sante |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA3075474C (fr) |
| WO (2) | WO2019049116A2 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11600365B2 (en) | 2017-12-12 | 2023-03-07 | Vyaire Medical, Inc. | Nasal and oral respiration sensor |
| KR20200111492A (ko) * | 2019-03-19 | 2020-09-29 | 삼성전자주식회사 | 전자 장치 및 전자 장치에서의 생체 정보 알림 방법 |
| JP7312857B2 (ja) * | 2019-06-11 | 2023-07-21 | バイエア メディカル，インク． | 鼻及び口呼吸センサ |
| KR20210022319A (ko) | 2019-08-20 | 2021-03-03 | 삼성전자주식회사 | 생체정보 추정 장치 및 방법 |
| WO2021127193A1 (fr) * | 2019-12-20 | 2021-06-24 | Xiant Technologies, Inc. | Unité mobile de localisation en temps réel |
| CN115444418A (zh) * | 2021-05-19 | 2022-12-09 | 英属开曼群岛商大峡谷智慧照明系统股份有限公司 | 一种智能人因照光方法 |
| WO2022265613A1 (fr) * | 2021-06-18 | 2022-12-22 | Cankaya Universitesi | Glucomètre en continu sans sang |
| US20230270337A1 (en) * | 2022-02-28 | 2023-08-31 | Hb Innovations, Inc. | System and method for video detection of breathing rates |
| CN114675553B (zh) * | 2022-03-22 | 2023-03-24 | 慕思健康睡眠股份有限公司 | 一种智能家居系统的控制方法、装置、设备及介质 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703689A (en) * | 1996-06-11 | 1997-12-30 | Varian Associates, Inc. | Optical spectrometer |
| US5823966A (en) * | 1997-05-20 | 1998-10-20 | Buchert; Janusz Michal | Non-invasive continuous blood glucose monitoring |
| US9430938B2 (en) * | 2013-03-04 | 2016-08-30 | Hello Inc. | Monitoring device with selectable wireless communication |
| US10361001B2 (en) * | 2015-09-23 | 2019-07-23 | Athena Gtx, Inc. | Autonomous critical care systems and integrated combat casualty care systems |
-
2018
- 2018-11-06 CA CA3075474A patent/CA3075474C/fr active Active
- 2018-11-06 WO PCT/IB2018/058718 patent/WO2019049116A2/fr active Application Filing
- 2018-11-08 WO PCT/IB2018/058758 patent/WO2019049117A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| CA3075474A1 (fr) | 2019-03-14 |
| WO2019049117A1 (fr) | 2019-03-14 |
| WO2019049116A2 (fr) | 2019-03-14 |
| WO2019049117A8 (fr) | 2019-06-06 |
| WO2019049116A3 (fr) | 2019-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11763665B2 (en) | Non-invasive multifunctional telemetry apparatus and real-time system for monitoring clinical signals and health parameters | |
| CA3075474C (fr) | Appareil multifonctionnel non invasif de telemesure et systeme en temps reel de surveillance de signaux cliniques et de parametres de sante | |
| JP7009556B2 (ja) | ヘルスケア用ウェアラブル装置及びそのための方法 | |
| US11229370B2 (en) | Portable device with multiple integrated sensors for vital signs scanning | |
| US10874345B2 (en) | Automated detection of breathing disturbances | |
| US11918386B2 (en) | Device-based maneuver and activity state-based physiologic status monitoring | |
| Anliker et al. | AMON: a wearable multiparameter medical monitoring and alert system | |
| US9655532B2 (en) | Wearable physiological monitoring and notification system based on real-time heart rate variability analysis | |
| US10022053B2 (en) | Simultaneous multi-parameter physiological monitoring device with local and remote analytical capability | |
| US20160000379A1 (en) | Method and apparatus for dynamic assessment and prognosis of the risks of developing pathological states | |
| US20150313484A1 (en) | Portable device with multiple integrated sensors for vital signs scanning | |
| US20150173628A1 (en) | Methods, Systems and Devices for Measuring Fingertip Heart Rate | |
| KR20150077684A (ko) | 생체 신호 기반 기능 운용 방법 및 이를 지원하는 전자 장치 | |
| US20130158364A1 (en) | Device Embodied to Measure Vital Parameters of a Patient | |
| US20220175309A1 (en) | Methods and apparatus for synchronizing cardiovascular and respiratory systems with stress and exertion analysis | |
| Dieffenderfer et al. | Wearable wireless sensors for chronic respiratory disease monitoring | |
| IL213004A (en) | Method and mechanism for determining critical care parameters | |
| US20200397315A1 (en) | Wearable fluidic device and system with integrated electronics | |
| US11678812B1 (en) | Systems and methods for monitoring hydration | |
| Preejith et al. | High altitude study on finger reflectance SpO 2 | |
| Gagnon-Turcotte et al. | Photoplethysmography-based derivation of physiological information using the BioPoint | |
| Srisuchinwong et al. | Acquiring unobtrusive sleep-related signals through an ESP32-based data logger | |
| US11633152B2 (en) | Method of monitoring respiratory rate in a health monitoring device | |
| US20240245307A1 (en) | Multi-sensor upper arm band for physiological measurements and algorithms to predict glycemic events | |
| Pryor | Feasibility of Physiological Monitoring Embedded in Smart Stuff |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220908 |
|
| EEER | Examination request |
Effective date: 20220908 |
|
| EEER | Examination request |
Effective date: 20220908 |
|
| EEER | Examination request |
Effective date: 20220908 |
|
| EEER | Examination request |
Effective date: 20220908 |
|
| EEER | Examination request |
Effective date: 20220908 |